Healthcare · Medical - Healthcare Information Services
Price
$27.82
Market Cap
$2.2B
Employees
675
Beta
1.04
Avg Volume
1,509,322
CEO
David J. Schlanger
Business Description
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
Business History
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
Stock Price / EPS (Diluted)
—
Stock Price: $27.82
EPS (Diluted): N/A
EPS (Diluted): N/A
EPS not available in income statement
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
4.24
Stock Price: $27.82
Total Equity: N/A
Shares: N/A
Total Equity: N/A
Shares: N/A
Equity not available in balance sheet
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
20.96
Market Cap: $2.18B
Total Debt: $0.00
Cash: $0.00
EBITDA: N/A
Total Debt: $0.00
Cash: $0.00
EBITDA: N/A
EBITDA not available
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$2.1B
Market Cap: $2.18B
Total Debt: $0.00
Cash: $0.00
Total Debt: $0.00
Cash: $0.00
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
1.70
Stock Price: $27.82
Revenue: N/A
Shares: N/A
Revenue: N/A
Shares: N/A
EV/Sales (Total value vs revenue — works when P/E can't)
API1.63
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
23.6%
Gross Profit: N/A
Revenue: N/A
Revenue: N/A
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
6.6%
Operating Income: N/A
Revenue: N/A
Revenue: N/A
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
4.5%
Net Income: N/A
Revenue: N/A
Revenue: N/A
ROE (Profit from shareholder equity)
Net Income / Total Equity
—
Net Income: N/A
Total Equity: N/A
Total Equity: N/A
Equity not in balance sheet
ROIC (Profit from all invested capital)
NOPAT / Invested Capital
—
Operating Income: N/A
Tax Rate: N/A
Equity: N/A
Total Debt: $0.00
Cash: $0.00
Tax Rate: N/A
Equity: N/A
Total Debt: $0.00
Cash: $0.00
Missing from API: Operating Income, Tax Rate, Equity
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
2.73
Current Assets: N/A
Current Liabilities: N/A
Current Liabilities: N/A
Debt/Equity (Leverage — debt vs equity)
Total Debt / Total Equity
—
Short-Term Debt: $0.00
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: N/A
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: N/A
Zero debt — this company carries no debt obligations. Strongest possible score.
Rev/Share (Top-line per share)
Revenue / Shares Outstanding
—
Revenue: N/A
Shares: N/A
Shares: N/A
Missing from API: Revenue, Shares
Book Value/Share (Net assets per share)
(Total Assets - Total Liabilities) / Shares
—
Total Equity: N/A
Shares: N/A
Shares: N/A
Missing from API: Total Equity, Shares
FCF/Share (Real cash generated per share)
(Operating Cash Flow + CapEx) / Shares
—
Operating CF: N/A
CapEx: $0.00
Shares: N/A
CapEx: $0.00
Shares: N/A
Missing from API: Operating CF, Shares
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $27.82
Stock Price: $27.82
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: N/A
Net Income: N/A
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares PGNY against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement
Requires paid FMP plan for this ticker
Analyst Estimates (Annual)
Last updated: Jun 26, 2026 10:37am (22h ago)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$1.5B $1.5B – $1.5B
|
$1.6B $1.6B – $1.6B
|
$1.7B $1.7B – $1.7B
|
$1.7B $1.7B – $1.7B
|
| EBITDA |
$162.1M $161.1M – $163.2M
|
$170.0M $170.0M – $170.1M
|
$182.5M $179.8M – $185.7M
|
$181.5M $178.8M – $184.7M
|
| Net Income |
$125.5M $121.6M – $143.2M
|
$154.6M $120.7M – $165.0M
|
$175.8M $172.4M – $179.9M
|
$156.6M $153.6M – $160.2M
|
| EPS | — | — | — | — |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for PGNY — it's generated by the pipeline (
market-narrative step).
No community reviews yet for PGNY.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30